Light-dark (L-D) synchronized Chlamydomonas grow during a 12-hr light period and divide by a series of mitoses into 4 or 8 daughter cells during the early part of the following 12-hr dark period. Sensitivity to the lethal effects of 9108 R X-irradiation varies throughout the L-D cycle: Mortality rises from 20% at the 1st hour to 40% at the 9th hour, to 70% at the onset of the dark; it reaches a peak of about 85% at about the 14th hour, just before the first cytokinesis, and then returns to a level of about 45% when cell division has been completed (after data correction for multiplicity of targets per colony-forming unit). Most lethally affected cells complete at least one set of divisions (into 4 or 8 daughter cells) before they die; however, exposure shortly before the first nuclear division results in two sets of divisions before death, suggesting that these cells were committed in some way at the time of irradiation to divide again 24 hr later. Some single cells exposed prior to cytokinesis exhibit mixed-colony formation: About half of their progeny die and half survive, indicating that prior to cytokinesis there are perhaps two radiation-sensitive "targets" per cell.
Skip Nav Destination
Research Article| May 01 1976
Cell Cycle Dependent X-Ray-Induced Death in Chlamydomonas reinhardi
Radiat Res (1976) 66 (2): 288–302.
- Views Icon Views
- Share Icon Share
- Search Site
Helen E. Gruber, D. S. Nachtwey; Cell Cycle Dependent X-Ray-Induced Death in Chlamydomonas reinhardi. Radiat Res 1 May 1976; 66 (2): 288–302. doi: https://doi.org/10.2307/3574397
Download citation file:
Citing articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Monte Carlo Simulation of SARS-CoV-2 Radiation-Induced Inactivation for Vaccine Development
Ziad Francis, Sebastien Incerti, Sara A. Zein, Nathanael Lampe, Carlos A. Guzman, Marco Durante
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Studies of the Mortality of Atomic Bomb Survivors, Report 14, 1950–2003: An Overview of Cancer and Noncancer Diseases
Kotaro Ozasa, Yukiko Shimizu, Akihiko Suyama, Fumiyoshi Kasagi, Midori Soda, Eric J. Grant, Ritsu Sakata, Hiromi Sugiyama, Kazunori Kodama
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner